Bausch Health
BHC
#4557
Rank
โ‚น202.91 B
Marketcap
โ‚น547.01
Share price
0.67%
Change (1 day)
-11.99%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น88.14. In 2024 the company made an earnings per share (EPS) of -โ‚น10.90 an increase over its 2023 EPS that were of -โ‚น147.20.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-876.79%
2024-โ‚น10.90-92.59%
2023-โ‚น147.20160.89%
2022-โ‚น56.42-76.64%
2021-โ‚น241.5268.45%
2020-โ‚น143.38-68.91%
2019-โ‚น461.14-57.11%
2018-โ‚น1,075-272.22%
2017โ‚น624.35-199.29%
2016-โ‚น628.79798.7%
2015-โ‚น69.97-128.31%
2014โ‚น247.16-204.62%
2013-โ‚น236.25602.7%
2012-โ‚น33.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น21.81-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น86.32-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA